Abstract:Purpose In this study, we applied laser capture microdissection and a proteomic approach to identify novel nasopharyngeal carcinoma (NPC) biomarkers. Methods Proteins from pooled microdissected NPC and normal nasopharyngeal epithelial tissues (NNET) were separated by two-dimensional gel electrophoresis, and differential proteins were identified by mass spectrometry. Expression of the differential protein cytokeratin 18 in the above two tissues as well as 4 NPC cell lines was determined by Western blotting. Immunohistochemistry was also performed to detect the expression of cytokeratin 18 in 62 cases of primary NPC, 28 cases of NNET, and 20 cases of cervical lymph node metastases, and the correlation of its expression level with clinicopathologic features and clinical outcomes were evaluated. siRNA and in vitro cell invasion assay were used to check the correlation between the expression of cytokeratin 18 and invasive ability of NPC. Results Thirty-six differential proteins between the NPC and NNET were identified. The expression level of cytokeratin 18 in the two types of tissues was confirmed by Western blotting and related to differentiation degree and metastatic potential of the NPC cell lines. Significant cytokeratin 18 down-regulation was observed in NPC versus NNET ( P = 0.000), whereas significant cytokeratin 18 up-regulation was observed in lymph node metastasis versus primary NPC ( P = 0.001). In addition, cytokeratin 18 down-regulation was significantly correlated with poor histological differentiation ( P = 0.000), whereas cytokeratin 18 up-regulation was significantly correlated with advanced clinical stage ( P = 0.019), recurrence ( P = 0.000), and regional lymph node metastasis ( P = 0.001), and distant metastasis ( P = 0.000). And down-regulated cytokeratin 18 expression by siRNA significantly decreased in vitro invasive ability of 5-8F cells. Furthermore, survival curves showed that patients with cytokeratin 18 up-regulation had a poor prognosis ( P = 0.000). Univariate analysis (Cox’s proportional hazards model) showed that WHO histologic type ( P = 0.025), lymph node metastasis ( P = 0.007), distant metastasis ( P = 0.005), recurrence ( P = 0.000), and cytokeratin 18 ( P = 0.000) were significantly associated with the prognosis of NPC. Multivariate analysis confirmed that lymph node metastasis ( P = 0.012), distant metastasis ( P = 0.009), recurrence ( P = 0.006), and cytokeratin 18 ( P = 0.001) were independent prognostic indicators. Conclusions The data suggest that cytokeratin 18 is a potential biomarker for the differentiation and prognosis of NPC, and its dysregulation might play an important role in the pathogenesis of NPC.

Identification and Characterization of a Novel Nasopharyngeal Carcinoma-Associated Peptide: NAP-1

Identification of Galectin-1 As A Novel Biomarker in Nasopharyngeal Carcinoma by Proteomic Analysis

Transcriptional Patterns, Biomarkers and Pathways Characterizing Nasopharyngeal Carcinoma of Southern China

Identification Of Novel Nasopharyngeal Carcinoma Biomarkers By Laser Capture Microdissection And Proteomic Analysis

Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads.

Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma

Identification of Candidate Biomarkers for the Early Detection of Nasopharyngeal Carcinoma by Quantitative Proteomic Analysis.

Identification of nasopharyngeal carcinoma antigens that induce humoral immune response by proteomic analysis.

Proteomic Analysis to Identify Cytokeratin 18 As a Novel Biomarker of Nasopharyngeal Carcinoma

Identification of a Nasopharyngeal Carcinoma-related EST and Sequence Analysis of its Full-length cDNA

[Screening and Identification of Human Nasopharyngeal Carcinoma-Associated Antigens].

Identification of Differentially Expressed Genes in Nasopharyngeal Carcinoma by Means of the Atlas Human Cancer Cdna Expression Array

The identification of key genes in nasopharyngeal carcinoma by bioinformatics analysis of high-throughput data

Decreased Expression of Updated NESG1 in Nasopharyngeal Carcinoma: Its Potential Role and Preliminarily Functional Mechanism.

Cloning, expression, and mutation analysis of NOR 1 , a novel human gene down-regulated in HNE 1 nasopharyngeal carcinoma cell line

Microarray Analysis of Novel Genes Involved in Nasopharyngeal Carcinoma

Expressions of PLAC8 Protein in Nasopharyngeal Carcinoma Cells and Related Clinical Significance

Analysis and Molecular Cloning of Differentially Expressing Genes in Nasopharyngeal Carcinoma.

Expression and Clinical Significance of Programmed Death Ligand 1 in Nasopharyngeal Carcinoma.

Functional analysis of the nasopharyngeal carcinoma primary tumor-associated gene interaction network

Molecular Cloning of a Novel Gene Located on Chromosome 3p25.3 and an Analysis of Its Expression in Nasopharyngeal Carcinoma